Equities

Artemis Medicare Services Ltd

ARTEMISMED:NSI

Artemis Medicare Services Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)280.05
  • Today's Change7.55 / 2.77%
  • Shares traded262.97k
  • 1 Year change+75.03%
  • Beta1.6657
Data delayed at least 15 minutes, as of Nov 14 2024 10:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Artemis Medicare Services Ltd grew revenues 19.14% from 7.37bn to 8.79bn while net income improved 27.32% from 385.98m to 491.41m.
Gross margin--
Net profit margin6.27%
Operating margin11.10%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, cash reserves at Artemis Medicare Services Ltd fell by 82.60m. However, the company earned 2.24bn from its operations for a Cash Flow Margin of 25.44%. In addition the company used 869.90m on investing activities and also paid 301.24m in financing cash flows.
Cash flow per share6.92
Price/Cash flow per share37.91
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Artemis Medicare Services Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 26.70%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)10.92%
EPS growth(5 years)17.92
EPS (TTM) vs
TTM 1 year ago
36.32
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.